ELEVANCE HEALTH, INC. Derivative Asset
ELEVANCE HEALTH, INC. (ELV) had Derivative Asset of $62.00 million as of 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2026-02-06
- 2025-12-31: Derivative Asset $62.00M.
- 2024-12-31: Derivative Asset $5.00M.
| Period end | Derivative Asset |
|---|---|
| 2025-12-31 | $62.00M 10-K · filed 2026-02-06 |
| 2024-12-31 | $5.00M 10-K · filed 2026-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |